SRS4382580 SAMN10973236 GSM3613420 Ovary_n3 9606 Homo sapiens bioproject 523366 source_name Ovary tissue cell type Ovary tissue treatment none SRS4382581 SAMN10973235 GSM3613421 Breast_n1 9606 Homo sapiens bioproject 523366 source_name Breast tissue cell type Breast tissue treatment none SRS4382583 SAMN10973233 GSM3613423 Prostate_n1 9606 Homo sapiens bioproject 523366 source_name Prostate tissue cell type Prostate tissue treatment none SRS4382585 SAMN10973231 GSM3613425 Prostate_n3 9606 Homo sapiens bioproject 523366 source_name Prostate tissue cell type Prostate tissue treatment none SRS4382586 SAMN10973230 GSM3613426 SKOV3ip1_Lipofectamin_n1 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment Lipofectamine 2000 (Invitrogen) SRS4382589 SAMN10973227 GSM3613429 SKOV3ip1_DKC1_KD_s1_n2 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment 10nM DKC1 targeting siRNA 1 using Lipofectamine 2000 (Invitrogen) SRS4382579 SAMN10973237 GSM3613419 Ovary_n2 9606 Homo sapiens bioproject 523366 source_name Ovary tissue cell type Ovary tissue treatment none SRS4382582 SAMN10973234 GSM3613422 Breast_n2 9606 Homo sapiens bioproject 523366 source_name Breast tissue cell type Breast tissue treatment none SRS4382584 SAMN10973232 GSM3613424 Prostate_n2 9606 Homo sapiens bioproject 523366 source_name Prostate tissue cell type Prostate tissue treatment none SRS4382587 SAMN10973229 GSM3613427 SKOV3ip1_Lipofectamin_n2 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment Lipofectamine 2000 (Invitrogen) SRS4382588 SAMN10973228 GSM3613428 SKOV3ip1_DKC1_KD_s1_n1 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment 10nM DKC1 targeting siRNA 1 using Lipofectamine 2000 (Invitrogen) SRS4382590 SAMN10973226 GSM3613430 SKOV3ip1_DKC1_KD_s2_n1 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment 10nM DKC1 targeting siRNA 2 using Lipofectamine 2000 (Invitrogen) SRS4382591 SAMN10973225 GSM3613431 SKOV3ip1_DKC1_KD_s2_n2 9606 Homo sapiens bioproject 523366 source_name SKOV3ip1 cell line cell type Ovarian serous cystadenocarcinoma growth protocol grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. Cell propagation and passaging were as recommended by ATCC (American Type Culture Collection). Cells were trypsinized and collected in 5X106 pellets resuspended in 700ul TRIzol (Ambion) and kept at -80°C until RNA extraction treatment 10nM DKC1 targeting siRNA 2 using Lipofectamine 2000 (Invitrogen) SRS4382578 SAMN10973199 GSM3613418 Ovary_n1 9606 Homo sapiens bioproject 523366 source_name Ovary tissue cell type Ovary tissue treatment none SRS7543249 SAMN16489414 GSM4838073 Breast_n3 9606 Homo sapiens bioproject 523366 source_name Breast tissue cell type Breast tissue treatment none